AI-Supported Double Mammogram Reading Improves Detection Rate

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 15, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 14, 2025 -- Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection rate, without affecting the recall rate, compared with standard double reading, according to a study published online Jan. 7 in Nature Medicine.

Nora Eisemann, Ph.D., from the Institute for Social Medicine and Epidemiology at the University of Lübeck in Germany, and colleagues compared the performance of AI-supported double reading to standard reading (without AI) among women aged 50 to 69 years undergoing organized mammography screening at 12 sites in Germany. Radiologists voluntarily chose whether to use the AI system or not. A total of 463,094 women were screened (260,739 with AI support) by 119 radiologists from July 2021 to February 2023.

The researchers found that the breast cancer detection rate for radiologists in the AI-supported screening group was 6.7 per 1,000, which was 17.6 percent higher than the rate of 5.7 per 1,000 achieved in the control group. In the AI group, the recall rate was 37.4 per 1,000, which was lower than and noninferior to that seen in the control group (38.3 per 1,000). The positive predictive value of recall was 17.9 and 14.9 percent in the AI and control groups, respectively; the positive predictive value of biopsy was 64.5 and 59.2 percent, respectively.

"Our findings substantially add to the growing body of evidence suggesting that AI-supported mammography screening is feasible and safe and can reduce workload," the authors write.

Several authors disclosed ties to medical technology companies, including Vara, which funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-16 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords